Stock listing

Cosmo Pharmaceuticals Nv

Selected listing: 0RGI · LSE · CHF · GB

Cosmo Pharmaceuticals Nv (LSE:0RGI), Health Technology. Latest release Aug 14, 2026: Cosmo Announces SIX Ticker Symbol Change to "CMHC".

0RGI:LSECHFGBUpdated August 31, 2026

Ticker: LSE:0RGI
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LSE
Currency: CHF

About Cosmo Pharmaceuticals Nv

The company specializes in developing and commercializing innovative therapeutic products. Cosmo focuses on areas such as gastrointestinal diseases and has a strong commitment to research and development.

Latest news from Cosmo Pharmaceuticals Nv

Cosmo Announces SIX Ticker Symbol Change to "CMHC"

August 14, 2026

Cosmo Reports Double-Digit Recurring Revenue Growth in H1 2026, Advances Clascoterone 5% Topical Solution Toward Regulatory Submission, and Confirms Full-Year Guidance

July 23, 2026

Invitation to Cosmo's Half-Year 2026 Financial Results Webcast on 23 July 2026

July 1, 2026

Cosmo Welcomes the Launches of Winlevi(R) in Austria and Germany

June 15, 2026

Cosmo Welcomes the Launch of Winlevi(R) in Key European Markets by Its Partner Glenmark

June 11, 2026

All Cosmo Pharmaceuticals Nv news →

Research Cosmo Pharmaceuticals Nv

Cosmo Pharmaceuticals Nv company profile

View the public company page for Cosmo Pharmaceuticals Nv on 6ix.

Cosmo Pharmaceuticals Nv news

Read company news and market updates connected to Cosmo Pharmaceuticals Nv.

Cosmo Pharmaceuticals Nv investor events

Find investor webinars, events, and replay context for Cosmo Pharmaceuticals Nv.